Clinical Trial Update: Anti-Inflammatory Agent in Sinusitis [Phase 2]

View source ↗

Summary

Phase 2 trial results for an anti-inflammatory agent in nasal polyps (sinusitis) have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Polyps

Snippet

Sponsor: Northwestern University | Conditions: Nasal Polyps | Phase 2 | Status: COMPLETED | Results posted: 2022-05-25